Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000486236 | SCV000565758 | uncertain significance | not provided | 2016-06-10 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the TMEM43 gene. Haywood et al. (2013) observed theE124K variant in two unrelated individuals with ARVC who had a family history of ARVC/DCM, however, theyalso observed this variant in a homozygous state in a control individual. Segregation analysis of E124K with diseasein these families was not completed (Haywood et al., 2013). The E124K variant was also reported in a 47-year-oldfemale with minimal symptoms and no family history of ARVC, who also harbored a DSP variant of uncertainsignificance (Baskin et al., 2013). The NHLBI Exome Sequencing Project and the 1000 Genomes Project reportE124K was observed in 13/8600 (0.2%) alleles from individuals of European background and in 3/694 (0.4%) allelesfrom individuals of Ad Mixed American background, indicating it may be a rare benign variant in these populations.However, the E124K variant is a non-conservative amino acid substitution, which is likely to impact secondaryprotein structure as these residues differ in polarity, charge, size and/or other properties, and this substitution occurs ata position that is conserved across species. Nonetheless, in silico analysis is inconsistent in its predictions as towhether or not the variant is damaging to the protein structure/function.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign.This result cannot be interpreted for diagnosis or used for family member screening at this time. |
Labcorp Genetics |
RCV000797310 | SCV000936859 | uncertain significance | Long QT syndrome | 2024-09-06 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 938 of the CACNA1C protein (p.Ile938Thr). This variant is present in population databases (rs377165829, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 308140). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CACNA1C protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002436155 | SCV002749465 | benign | Cardiovascular phenotype | 2022-02-14 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genomics Laboratory, |
RCV005255487 | SCV005908061 | uncertain significance | Timothy syndrome; arrhythmogenic disorders | 2023-01-13 | criteria provided, single submitter | clinical testing | The p.Ile938Thr variant in the CACNA1C gene has not been previously reported in association with disease. This variant has been identified in 4/30596 South Asian chromosomes (6/249248 chromosomes overall) by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant is present in ClinVar (Variation ID: 308140). The CACNA1C gene has fewer missense variants in the general population than expected. A low rate of missense variation may suggest that this gene is intolerant to missense variation. Computational tools predict that this variant is deleterious; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, the significance of the p.Ile938Thr variant is uncertain. Additional information is needed to resolve the significance of this variant. [ACMG evidence codes used: PP2; PP3] |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV002436155 | SCV006067332 | uncertain significance | Cardiovascular phenotype | 2025-04-09 | criteria provided, single submitter | clinical testing |